RACKLEY C E. New clinical markers predictive of cardiovascular disease: the role of inflammatory mediators[J]. Cardiology in Review, 2004, 12(3):151-157.
[2]
YUAN G, AI-SHALI K Z, HEGELE R A. Hypertriglyceridemia: its etiology, effects and treatment[J]. Canadian Medical Association Journal, 2007, 176(8):1113-1120.
[3]
ALBERT C M, MA J, RIFAI N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death[J]. Circulation, 2002, 105(22): 2595-2599.
[4]
AZIZ N, FAHEY J L, DETEL R, et al. Analytical performance of a high sensitive C-reactive protein based immunoassay and the effects of laboratory variables on levels of protein in blood[J]. Clinical and Diagnostic Laboratory Immunology, 2003, 10:652-657.
[5]
SCHOENBECK U, LIBBY P. CD40 signaling and plaque instability[J]. Circulation Research, 2001, 89(12):1092-1103.
[6]
SCHONBECK U, SUKHOVS G K, SHIMIZU K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice[J]. Proceedings of the National Academy of Sciences, USA., 2000, 97(13):7458-7463.
[7]
ZHU Z R, AGREN J, MANNISTO S, et al. Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease[J]. Nutrition & Cancer, 1995, 24(2):151-160.
[8]
BALDASSARRE D, AMATO M, ELIGINI S, et al. Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention[J]. Annals of Medicine, 2006, 38(5):367-375.
[9]
HJERKINN E M, ABDELNOOR M, BREIVIK L, et al. Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia[J]. European Journal of Cardiovascular Prevention & Rehabilitation, 2006, 13(3):325-333.
KATO T, HANCOCK R L, MOHAMMADPOUR H, et al. Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice[J]. Cancer Letter, 2002, 187(2):169-177.
CIPOLLONE F, CHIARELLI F, DAVI G, et al. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control[J]. Diabetologia, 2005, 48(6):1216-1224.
ELABBASSI W, AL-NOORYANI A. Acute coronary syndrome. An acute inflammatory syndrome[J]. Saudi Medical Journal, 2006, 27(12):1799-1803.
[22]
MATSUSHITA K, YATSUYA H, TAMAKOSHI K. Epidemiology of acute coronary syndrome[J]. Japanese Journal of Clinical Medicine, 2006, 64(4):625-632.
[23]
LEE J Y, PLAKIDAS A, LEE W H, et al. Differential modulation of toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids[J]. Journal of Lipid Research, 2003, 44(3):479-486.
[24]
VALERIO S, PASQUALE P, LUISA L, et al. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients[J]. Circulation, 2005, 111(4):412-419.
